Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TG Therapeutics Inc (TGTX) vs Twilio Inc (TWLO) Price & Performance

TG Therapeutics IncTrade
Twilio IncTrade

Price performance (Past 24H)

Key statistics

TG Therapeutics Inc vs Twilio Inc — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Twilio Inc trades at $195.94 (market cap $31.15B). The key difference: Twilio Inc is far larger — about 3.8× TG Therapeutics Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Twilio Inc nearer its low. Which is the better fit depends on your goals.

TGTXTWLO
Market Cap
$8.26B$31.15B
Sector
HealthTechnology
52-Week High
$59.06$236.64
52-Week Low
$26.39$92.44
Enterprise Value
$8.50B$29.87B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.

Read more on TGTX

About Twilio Inc

Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.

Read more on TWLO